Upfront consolidation treatment with 131I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma

• Main Authors: Jianhua Feng (Author), Frankie WT Cheng (Author), Alex WK Leung (Author), Vincent Lee (Author), Eva WM Yeung (Author), Hoi Ching Lam (Author), Jeanny Cheung (Author), Grace KS Lam (Author), Terry TW Chow (Author), Carol LS Yan (Author), Chi Kong Li (Author)
• Format: Book
• Published: Wiley, 2020-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Importance 131I‐metaiodobenzylguanidine (131I‐mIBG) has a significant targeted antitumor effect for neuroblastoma. However, currently there is a paucity of data for the use of 131I‐mIBG as a "front‐line" therapeutic agent in those patients with newly diagnosed high‐risk neuroblast...